MEDA PHARMACEUTICALS INC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Phase 3

Completed

Conditions: Perennial Allergic Rhinitis

Interventions: Drug: 0.15% azelastine hydrochloride
Drug: Mometasone furoate

First Posted Date: 2008-07-22

Last Posted Date: 2015-05-21

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 703

Registration Number: NCT00720382

Locations: 🇺🇸
Allergy and Asthma DTC, Tallahassee, Florida, United States
🇺🇸
Allergy and Consultants of NJ/PA, Collegeville, Pennsylvania, United States
🇺🇸
Pharmaceutical Research & Consulting Inc, Dallas, Texas, United States

and more 55 locations

A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Placebo
Drug: 0.1% azelastine hydrochloride 1096 mcg daily
Drug: 0.15% azelastine hydrochloride 1644 mcg daily

First Posted Date: 2008-07-22

Last Posted Date: 2010-03-02

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 526

Registration Number: NCT00720278

Locations: 🇺🇸
Atlantic Research Center, Ocean, New Jersey, United States
🇺🇸
Research Asthma, Sinus and Allergy Centers, Warren, New Jersey, United States
🇺🇸
National Allergy, Asthma and Urticaria of Charleston, Charleston, South Carolina, United States

and more 26 locations

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: 0.15% azelastine hydrochloride Nasal Spray
Drug: Placebo nasal spray

First Posted Date: 2008-07-22

Last Posted Date: 2010-02-02

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 481

Registration Number: NCT00719862

Locations: 🇺🇸
Allergy Consultants PA, Verona, New Jersey, United States
🇺🇸
UPMC-ENT, Pittsburgh, Pennsylvania, United States
🇺🇸
Kansas City Allergy and Asthma, Overland Park, Kansas, United States

and more 31 locations

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

Phase 3

Completed

Conditions: Perennial Allergic Rhinitis

Interventions: Drug: Placebo
Drug: 0.15% azelastine hydrochloride
Drug: 0.1% azelastine hydrochloride

First Posted Date: 2008-07-10

Last Posted Date: 2011-06-08

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 581

Registration Number: NCT00712920

Locations: 🇺🇸
National Allergy, Asthma and Urticaria of Charleston, Charleston, South Carolina, United States
🇺🇸
AAIR Research Center, Rochester, New York, United States
🇺🇸
Allergy Asthma and Dermatology Research, Lake Oswego, Oregon, United States

and more 39 locations

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Phase 3

Completed

Conditions: Lower Back Pain

Interventions: Drug: Carisoprodol SR 700 mg
Drug: Carisoprodol SR 500 mg
Drug: Placebo

First Posted Date: 2008-05-05

Last Posted Date: 2012-11-21

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 830

Registration Number: NCT00671879

Locations: 🇺🇸
Lovelace Scientific Resources, Inc., Burbank, California, United States
🇺🇸
Crest Clinical Trials, Inc., Santa Ana, California, United States
🇺🇸
Orthopaedic Assoc. of S. Broward, P.A., Hollywood, Florida, United States

and more 68 locations

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Phase 3

Completed

Conditions: Lower Back Pain

Interventions: Drug: Carisoprodol SR
Drug: Placebo

First Posted Date: 2008-05-05

Last Posted Date: 2011-11-09

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 840

Registration Number: NCT00671502

Locations: 🇺🇸
Sunrise Medical Research #501, Plantation, Florida, United States
🇺🇸
Perimeter Institute for Clinical Research, Inc., Atlanta, Georgia, United States
🇺🇸
Palm Beach Research Center, West Palm Beach, Florida, United States

and more 65 locations

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Placebo
Drug: 0.15% Azelastine Hydrochloride

First Posted Date: 2008-04-17

Last Posted Date: 2015-04-13

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 536

Registration Number: NCT00660829

Locations: 🇺🇸
Allergy and Asthma Associates, Austin, Texas, United States
🇺🇸
Central Texas Research, New Braunfels, Texas, United States
🇺🇸
Sylvana Research Associates, San Antonio, Texas, United States

and more 3 locations

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: MP29-02
Drug: placebo
Drug: azelastine Hcl
Drug: fluticasone propionate

First Posted Date: 2008-04-17

Last Posted Date: 2012-07-27

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 607

Registration Number: NCT00660517

Locations: 🇺🇸
Southwest Allergy and Asthma Center, P.A., San Antonio, Texas, United States
🇺🇸
Allergy and Asthma Care, Waco, Texas, United States
🇺🇸
Sylvana Research Associates, San Antonio, Texas, United States

and more 4 locations

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Placebo
Drug: azelastine Hcl
Drug: azelastineHcl / fluticasone propionate
Drug: fluticasone propionate

First Posted Date: 2008-04-02

Last Posted Date: 2012-09-26

Lead Sponsor: Meda Pharmaceuticals

Target Recruit Count: 832

Registration Number: NCT00651118

Locations: 🇺🇸
Jane Lee, MD, PA Research Center, Dallas, Texas, United States
🇺🇸
Allergy Research Foundation, Los Angeles, California, United States
🇺🇸
Asthma, Inc., Seattle, Washington, United States

and more 36 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy